Preimplantation Genetic Diagnosis (pgd) Per Embryo
Preimplantation genetic diagnosis, or PGD, is the genetic testing of embryos created through in vitro fertilization, or IVF, before any embryo is placed in the uterus, so that only embryos without the condition being studied are transferred (MedlinePlus). Modern clinics and regulators now call the whole family of tests preimplantation genetic testing, or PGT, but the service name still says PGD (Genomics Education, NHS England). If you develop severe or worsening pelvic or abdominal pain, rapid weight gain or severe bloating, repeated vomiting, shortness of breath, chest pain, a swollen or painful leg, or heavy vaginal bleeding during a stimulation cycle or after egg retrieval, do not wait for a planned transfer or a flight: seek urgent local medical care now (Royal College of Obstetricians and Gynaecologists). This guide walks you through what PGD and PGT involve, who they are for, how to prepare, and what to watch for if you choose to have the testing abroad.
What PGD is
PGD reduces the risk of having a child with a particular genetic or chromosomal disorder by testing each IVF embryo first (MedlinePlus). PGT is a type of IVF: an embryo is made in the laboratory, a few cells are tested, and only embryos without the disease-causing change are transferred (Genomics Education, NHS England). The testing itself is done by taking a small number of cells from each embryo in the lab and testing them for certain genetic changes (MedlinePlus). The name moved from PGD to PGT because the technique covers more than diagnosis of one condition, and the three variants are now named by what they test (Genomics Education, NHS England):
- PGT-M (monogenic, formerly called PGD) tests embryos for one specific inherited single-gene condition, such as cystic fibrosis, sickle cell anaemia, Tay-Sachs disease, Huntington's disease or thalassaemia (Genomics Education, NHS England).
- PGT-A (aneuploidy testing) checks embryos for the right number of chromosomes, and is used in cases of recurrent miscarriage of unknown cause and to screen for chromosome problems such as Down syndrome (Genomics Education, NHS England).
- PGT-SR (structural rearrangements) tests embryos for people who carry a chromosomal translocation or inversion, a common cause of recurrent miscarriage (HFEA).
PGD is not a general screening for every possible problem. It tests only the specific condition being studied, and a positive result is meant to be confirmed by testing during a later pregnancy (ASRM). Because it depends on IVF, it sits inside the wider fertility picture: the IVF cycle that always comes first is In Vitro Fertilization, often combined with ICSI With IMSI, single-sperm injection, and the results are usually read through Diagnostics, Radiology, the ultrasound monitoring during stimulation, and Pathology, the molecular laboratory where the embryo testing is done (HFEA). The genetic assessment that starts the path is a Consultation / Check-up, and the whole service sits under the Obstetrics And Gynecology umbrella. If the reason you need IVF is a surgical problem such as tubal disease, endometriosis or fibroids, that operation has its own page at Surgery.
The rest of the fertility family, where a genetic condition cannot be avoided with your own eggs and sperm, or where embryos need to be stored, lives on these sibling pages: Frozen Embryo Transfer Cycle (the usual way PGT embryos are transferred once results are read), Egg Donation, Embryo Donation, Egg Freezing, Egg And Ovarian Cortex Freezing, Embryo Freezing, Embryo Oocyte And Sperm Cryopreservation, Clomid Treatment, Artificial Insemination (donor), Assisted Laser Hatching and Egg donation with Sperm Donation.
How PGD works
The pathway runs in time order, and each step exists for a reason. It begins with fertility and genetic assessment rather than with eggs. A genetic counsellor experienced with both PGT and IVF should explain the risks, benefits and limits before you commit, because the test is optional and the decision carries weight (ASRM). Carrier testing comes first, because it identifies whether either partner carries one copy of a gene change that, in two copies, causes a disorder, and testing both partners shows a couple's risk of an affected child (MedlinePlus).
Then the IVF cycle starts. Fertility hormones stimulate the ovaries to produce several eggs, which are collected and mixed with sperm in the laboratory (HFEA). One cycle of IVF takes between four and six weeks and involves stimulation, monitoring with blood tests or ultrasound, egg collection and embryo transfer (HFEA). The eggs are collected under sedation or general anaesthetic in a procedure taking about half an hour, which is the one invasive step in the whole of PGD (HFEA). When sperm quality is low, ICSI is used, a single sperm injected into the egg by an embryologist, which keeps all embryos genetically from the intended parents (HFEA).
The embryo is then cultured to the blastocyst stage, around day five to day seven after fertilisation, when enough cells have grown to test without harming development (Genomics Education, NHS England). At the biopsy step a small number of cells are taken from the embryo in the lab. This is a laboratory step with no entry on the patient's body, which is why the testing itself is far less risky than the IVF cycle that feeds it (MedlinePlus). Each embryo is tested separately, and that is the point of the "per embryo" name: results apply embryo by embryo (MedlinePlus).
Only embryos without the disease-causing variant are transferred, and couples can instead choose to freeze their embryos for future use (Genomics Education, NHS England). After PGT the embryo is more often frozen and transferred at a later date rather than transferred fresh two to six days after creation, because the lab needs time to read the results (HFEA). The transfer itself needs no anaesthetic (HFEA), and what follows is the two-week wait and a pregnancy test.
Who it is for, and when not to wait
PGT is offered when a significant reproductive risk is identified, and acceptance is optional: you may accept or decline it (ASRM). It suits people who are known carriers or affected by a single-gene disorder, people who carry a chromosomal translocation and have had recurrent miscarriage, and, for aneuploidy testing, women of advanced maternal age. It is indication-based, not a population screen: there is no recommended universal frequency, and PGT-A used as routine screening for all patients has not been shown to improve live-birth rates (ASRM).
The reason to act rather than wait is the risk sitting in each pregnancy (MedlinePlus). Two people who each carry one copy of a gene change for an autosomal recessive disorder have a 25 percent, or 1 in 4, chance with each pregnancy of having an affected child, and that chance stays at 1 in 4 for every pregnancy, even after an affected child (MedlinePlus). For an autosomal dominant condition such as Huntington's disease, an affected parent has a 50 percent, or 1 in 2, chance of passing the altered gene to each child (MedlinePlus). Not doing PGT leaves those figures in place, and the untreated condition can mean a sick child, a miscarriage, a termination, or in some disorders a fatal childhood disease. Not pursuing PGT is a legitimate choice, though, and a person who declines it can instead choose donor eggs, sperm or embryos, adoption, or testing during pregnancy (HFEA).
One caution about scope. Where PGT is used to choose an embryo for a non-medical reason, such as family balancing by sex, it becomes elective, and most countries restrict or ban those uses (ASRM). That is a real legal difference between destinations and it belongs at the front of your planning, not an afterthought.
How to prepare
Each item on this list serves a purpose. Bring your prior fertility and genetic results so the clinic does not repeat tests already done. Keep a current list of every medication you take, because some affect the stimulation protocol and the anaesthetic. If carrier testing and genetic counselling have not been done, arrange them first, because the test's accuracy depends on knowing exactly which condition and which genetic change are being looked for (ASRM). Plan realistic time off and, if travelling, a stay long enough to cover a full cycle plus results and transfer, because a single healthy baby is the aim and one cycle does not guarantee one. IVF carries a high emotional toll, so arrange support from people who understand the experience before you start (HFEA). And if you are going abroad, sort travel insurance that covers assisted reproduction before booking, not after.
Writing your questions down helps you get the answers that matter. You can say these exact words to your clinic and genetic counsellor:
- "Which type of PGT, PGT-M, PGT-A or PGT-SR, would be involved for my specific condition, and what does the test actually look for?" (ASRM)
- "What is my realistic chance of an unaffected live birth per cycle at my age, and how many cycles should I expect?" (Genomics Education, NHS England)
- "What are the limits of the test, how often can results be inconclusive or wrong, and how would a positive result be confirmed?" (ASRM)
- "If I develop OHSS or a blood clot after retrieval, who treats me and who pays, especially if I am abroad?" (RCOG)
What to expect, risks and recovery
The benefit of PGD and PGT is the chance of having a baby unaffected by the condition being studied: tested embryos free of the condition are placed back into the womb to continue developing (HFEA). A healthy live birth per cycle is not guaranteed, though, and success falls with age; there is no single clean published rate of an unaffected baby per cycle that you should treat as a promise (Genomics Education, NHS England).
The risks of treatment
The invasive heart of PGD is the IVF cycle it depends on. Egg retrieval under anaesthetic carries rare surgical risks, including infection, bleeding and bowel perforation (HFEA). The stimulation drugs can cause ovarian hyperstimulation syndrome (OHSS), a reaction in which fluid shifts from the bloodstream into the abdomen and around the lungs. Around a third of women develop mild OHSS, which is usually treated at home with fluids and pain relief, while fewer get moderate or severe OHSS, affecting just over 1 in 100 women, and in very rare cases severe OHSS can be life-threatening (HFEA; RCOG). Across IVF as a whole, OHSS affects 3 to 6 percent of women, and in rare cases it leads to fatal complications such as blood clots or kidney failure (MedlinePlus). A rare complication of OHSS is a blood clot in the legs or lungs, which shows as a swollen, tender leg or chest pain with breathlessness, and a very small number of deaths due to OHSS have been reported (RCOG).
Transferring more than one embryo raises the chance of a multiple pregnancy, and at least half of twins are born premature and underweight, which is why clinics favour an elective single embryo transfer (eSET), which has little effect on success rates (HFEA). An ectopic pregnancy, one that develops outside the womb, usually in the fallopian tube, can also occur, and women undergoing IVF may be more at risk (HFEA).
The test itself has limits. There is a small chance that PGT results are inaccurate, due to mosaicism within the blastocyst or allelic dropout, and a cycle can produce no usable embryos or no unaffected embryos at all (Genomics Education, NHS England). Beyond the medical, IVF carries a high emotional toll that is worth preparing for (HFEA). Most people recover fully from the cycle, and some do not (RCOG).
Call for medical help if you develop any signs of worsening OHSS: pain that is not improving, vomiting, urinary problems, chest pain or difficulty breathing (RCOG).
The risks of waiting
The other side of the balance is not acting. For a known carrier or affected person, each pregnancy carries the defined risk above, 1 in 4 for autosomal recessive conditions, up to 1 in 2 for autosomal dominant ones, and PGT exists specifically to lower that risk (MedlinePlus). Waiting leaves the condition's known trajectory in place, and for some disorders that means an affected child with serious illness. This is a decision you weigh on your own. But if you are a known carrier and not doing anything about it, the cost of delay is a real figure, not an abstraction.
How to prepare, and what to expect after
Recovery after egg retrieval takes a few days. After collection, avoid sex and strenuous exercise to protect the enlarged ovaries, but stay active to reduce the risk of a blood clot, because mild OHSS is managed at home with fluids and paracetamol (RCOG). OHSS symptoms usually resolve in 7 to 10 days and often settle by the next period, unless a pregnancy occurs, in which case they can last weeks (RCOG). A frozen embryo transfer is quick and needs no anaesthetic (HFEA).
Finding PGD abroad on MTR
Travelling abroad for PGD and PGT is a real option where the home country bans the test, restricts it to certain conditions, forbids sex selection, or keeps a long waiting list. Start with the law, because it decides whether your specific indication is even legal at your chosen destination. Non-medical sex selection is prohibited by law in Canada and in a number of European countries, and permitted in Israel only by approval in rare cases, so the same procedure is lawful in one country and not another (ASRM). Confirm which conditions the destination allows you to test for before you book anything.
Then judge the laboratory, not just the headline. A clinic's success claim matters only when it is per age, and measured as a live birth of an unaffected baby, not merely a clinical pregnancy, and only with the number of embryos tested and transferred made clear (Genomics Education, NHS England). Check that the embryology and molecular laboratory is accredited, and that the facility has emergency and blood-bank backup for the egg-retrieval step.
The logistics run for months. Plan time for multiple cycles, decide where to stay, and get a written aftercare route: who treats OHSS or a clot back home, and who pays (RCOG). Keep all records in English so your home doctors can follow up. Get travel insurance that covers assisted reproduction; standard policies exclude it. And time your flights: the risk of a blood clot is highest in the first three months after surgery, and long flights of more than four hours more than double the likelihood of a clot, so do not fly straight after egg retrieval without asking the clinic first (National Heart, Lung and Blood Institute).
To compare accredited providers, look at the PGD providers directory on MTR and read our guide to top medical tourism destinations worldwide.
This week, book a fertility and genetic assessment, gather your prior results, and write down your questions.
Medical disclaimer: This information is for general educational purposes and is not medical advice. Always consult a qualified healthcare professional about your individual situation.
Reviewed against authoritative medical sources (MedlinePlus, the US National Library of Medicine; the Genomics Education Programme, NHS England; the Human Fertilisation and Embryology Authority, HFEA; the American Society for Reproductive Medicine, ASRM; the Royal College of Obstetricians and Gynaecologists, RCOG; the National Heart, Lung and Blood Institute, NHLBI, US National Institutes of Health).
Last reviewed: 18 November 2026
Providers that provide Preimplantation Genetic Diagnosis (pgd) Per Embryo Service
| Providers | Score | Reviews | Location |
|---|---|---|---|
| Fertility And Genetics |
Not Rated |
0 | United States |
| Fertility Answers |
Not Rated |
0 | United States |
| Fertility Clinic |
Not Rated |
0 | Greece |
| Frisco Institute Of Reproductive Medicine |
Not Rated |
0 | United States |
| Garbhagudi Ivf Center Pvt Ltd |
Not Rated |
0 | India |
| Gayrettepe Florence Nightingale Hospital |
Not Rated |
0 | Turkey |
| Genetics & Ivf Institute |
Not Rated |
0 | United States |
| Gennima |
Not Rated |
0 | Greece |
| Genomee |
Not Rated |
0 | India |
| Ginefiv Clinic |
Not Rated |
0 | Spain |
| Ginemed Clinicas |
Not Rated |
0 | Spain |
| Girofiv |
Not Rated |
0 | Spain |
| Guy’s Hospital |
Not Rated |
0 | United Kingdom |
| Gynomed Centre For Women’s Health |
Not Rated |
0 | South Africa |
| High Care Fertility Center |
Not Rated |
0 | Spain |
| Hospital Universitari Dexeus (usp Instituto Dexeus S.a.) |
Not Rated |
0 | Spain |
| Hospital Universitario La Luz |
Not Rated |
0 | Spain |
| Houston Fertility Center |
Not Rated |
0 | United States |
| Imed Hospitales |
Not Rated |
0 | Spain |
| Imer Instituto De Medicina Reproductiva |
Not Rated |
0 | Spain |
